BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 202 found
  Current Search:  muscular: 542, dystrophy: 210, duchenne: 102     

HTML
100%
Medical industry unites for disease cure
8:04 PM PDT Features Group is looking for a way to treat muscular disease that kills boys before they reach adulthood.

By Brianna Bailey Some of the countrys top medical researchers arrived in Newport Beach on Thursday to help find a cure for a fatal...

Daily Pilot:  Mar 19 2010 6:32PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
66%
Galapagos to build cystic fibrosis drug pipeline
access the live audio webcast R&D Update presentation todayat 13.00 CET/8 AM Mechelen, Belgium; 19 March 2010 - Galapagos NV (Euronext: GLPG) announced the decision to pursue cystic fibrosis (CF) in its strategy to deliver breakthrough medicines to patients...
EuroInvestor.co.uk:  Mar 19 2010 6:32AM
Matching: muscular duchenne
Find similar documents
HTML
100%
Muscular Dystrophy - An NGO's Crusade to Help the Society
Medindia spoke to Dr.

Vishwanathan, DCH, MRCP, Ph.

D (Pediatric Neurology) Consultant Pediatric Neurologist and Founder President, Muscular Dystrophy Association India, a project that has crossed cultures and borders in research and facilities...

MedIndia:  Mar 18 2010 8:09AM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated...

Tech Divas:  Mar 18 2010 9:15PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

(Nasdaq:AVII).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make...

GlobeNewswire via MSN Money:  Mar 18 2010 12:42PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated...

Interest!ALERT:  Mar 18 2010 12:25PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

(Nasdaq:AVII).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make...

DMN Newswire:  Mar 18 2010 12:21PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GlobeNewswire via COMTEX) ----BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

(Nasdaq:AVII).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

FOXBusiness.com:  Mar 18 2010 12:03PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GlobeNewswire via COMTEX) ----BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

(Nasdaq:AVII).

The report includes financial, comparative and investment analyses, and pertinent industry information you need to...

FOXBusiness.com:  Mar 18 2010 12:01PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity
(GlobeNewswire via COMTEX News Network) -- BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc.

(Nasdaq:AVII).

The report includes financial, comparative and investment analyses, and pertinent industry information you...

StockHouse USA:  Mar 18 2010 11:07AM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...

SmartBrief:  Mar 18 2010 12:12AM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
63%
Grass-roots initiative raises more than $20 million to advance MDA's lifesaving mission
The spirit of St.

Patrick's Day is alive and well.

The Muscular Dystrophy Association today announced that, with 92 percent of some 10,000 retail locations reporting, its 2010 Shamrocks Against Dystrophy fundraiser is the most successful...

News-Medical.Net:  Mar 18 2010 6:11AM
Matching: muscular dystrophy
Find similar documents
HTML
63%
Competitive bidding program for durable medical equipment: Myths and realities
Medicare has been touting the merits of the "competitive" bidding program for durable, or home medical equipment and services (HME) to convince Congress that the program is good for seniors.

Unfortunately, proponents have conveyed misleading information and...

News-Medical.Net:  Mar 18 2010 10:46AM
Matching: muscular dystrophy
Find similar documents
HTML
100%
Scientists Discover Chemical That 'Protects' Hearts of Muscular Dystrophy Patients
Heart Disease News Font Size A chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients has been discovered by University of Minnesota Medical School scientists.

The chemical, which Medical School...

MedIndia:  Mar 17 2010 6:18PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...

Red Orbit:  Mar 17 2010 3:14PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...

NewsBlaze:  Mar 17 2010 1:44PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare
BioMarin Pharmaceutical Inc.

today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in Miami on Wednesday, March 24, 2010 at 9:30 a.m.

PR Newswire via MSN Money:  Mar 17 2010 1:22PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in...

FinanzNachrichten.de:  Mar 17 2010 1:16PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ BioMarin Pharmaceutical Inc.

(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...

Your Story:  Mar 17 2010 1:10PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Discovery Of Chemical That May Protect Hearts Of Muscular Dystrophy Patients
Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients - a fatal and most common form of muscular dystrophy in children.
Medical News Today:  Mar 16 2010 3:23PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
Medical News: Discovery Of Chemical That May Protect Hearts Of Muscular Dystrophy Patients
Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients - a fatal and most common form of muscular dystrophy in children.
BioFind:  Mar 16 2010 3:42PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results
Duchenne Muscular Dystrophy (DMD) -- AVI showed impressive levels of new dystrophin expression in DMD patients in a Phase 1 trial evaluating intramuscular injection of AVI-4658, AVI's lead drug candidate with potential to treat DMD by skipping...
FOXBusiness.com:  Mar 16 2010 12:28PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results Financial Results and Corporate Update Conference Call ..
Duchenne Muscular Dystrophy (DMD) -- AVI showed impressive levels of new dystrophin expression in DMD patients in a Phase 1 trial evaluating intramuscular injection of AVI-4658, AVI's lead drug candidate with potential to treat DMD by skipping...
PR inside:  Mar 16 2010 12:13PM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results
Duchenne Muscular Dystrophy (DMD) -- AVI showed impressive levels of new dystrophin expression in DMD patients in a Phase 1 trial evaluating intramuscular injection of AVI-4658, AVI's lead drug candidate with potential to treat DMD by skipping...
TradingMarkets:  Mar 16 2010 11:48AM
Matching: muscular dystrophy duchenne
Find similar documents
HTML
100%
AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results
Companies mentioned in this article: AVI BioPharma, Inc.

BOTHELL, WA -- (Marketwire) -- 03/16/10 -- AVI BioPharma, Inc.

(NASDAQ: AVII), a developer of RNA-based drugs, today reported financial results for the three and twelve months ending December 31, 2009...

Freshnews.com:  Mar 16 2010 12:47PM
Matching: muscular dystrophy duchenne
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.